Halozyme Therapeutics
Halozyme Therapeutics is an American biotechnology company that develops novel oncology therapies designed to target the tumor microenvironment and licenses a novel drug delivery technology through corporate partnerships. The company was founded in 1998 and went public in 2004.
-
Hylenex Injection 150 Units SDV 4 x 1mL 030621627000
Hylenex® recombinant human hyaluronidase enhances the absorption and dispersion of injected drugs and fluids, supporting efficient, predictable results in medical and aesthetic procedures.
$358.00 -
Hylenex Package: Hylenex Hyaluronidase, Human Recombinant, Preservative Free 150 Unit / mL Injection Single Dose Vial Box of 4 x 1 mL
Hylenex® recombinant human hyaluronidase enhances the absorption and dispersion of injected drugs and fluids, supporting efficient, predictable results in medical and aesthetic procedures.
$379.99
